Figure 9.
CNTs in cellular therapy. (a) MWCNT functionalization protocol with TAT-PEI-Biotin and OXA for glioma therapy to obtain the TBCNT@OXA system. (b) On the left, T2*-weighted pictures of tumours under treatment with control, CNT@OXA or TBCNT@OXA at various therapy days. On the right, images of haematoxylin and eosin staining of the tumours. Reproduced from Ref. [168] with permission from the Royal Society of Chemistry.